Literature DB >> 12070782

A functional promoter polymorphism in the macrophage migration inhibitory factor (MIF) gene associated with disease severity in rheumatoid arthritis.

J A Baugh1, S Chitnis, S C Donnelly, J Monteiro, X Lin, B J Plant, F Wolfe, P K Gregersen, R Bucala.   

Abstract

The macrophage migration inhibitory factor (MIF) is a potent pro-inflammatory cytokine and regulates the anti-inflammator effects of glucocorticoids. An important role for MIF within the cytokine cascade is to act in concert with endogenous glucocorticoids to control the set-point and magnitude of the inflammatory response. Elevated expression of MIF in the circulation and in the synovial joint has been documented in rheumatoid arthritis. MIF also has been linked to the development of joint damage and disease pathology in experimental animal models. We describe herein a novel CATT-tetranucleotide repeat polymorphism at position -794 of the human Mif gene and show that it functionally affects the activity of the MIF promoter in gene reporter assays. We describe four genotypes which comprise 5, 6, 7, or 8-CATT repeat units and show that the 5-CATT allele has the lowest level of basal and stimulated MIF promoter activity in vitro. The presence of the low expressing, 5-CATT repeat allele correlated with low disease severity in a cohort of rheumatoid arthritis patients.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12070782     DOI: 10.1038/sj.gene.6363867

Source DB:  PubMed          Journal:  Genes Immun        ISSN: 1466-4879            Impact factor:   2.676


  130 in total

Review 1.  D-dopachrome tautomerase (D-DT or MIF-2): doubling the MIF cytokine family.

Authors:  Melanie Merk; Robert A Mitchell; Stefan Endres; Richard Bucala
Journal:  Cytokine       Date:  2012-04-14       Impact factor: 3.861

Review 2.  Macrophage migration inhibitory factor (MIF): a promising biomarker.

Authors:  Gerrit Grieb; Melanie Merk; Jürgen Bernhagen; Richard Bucala
Journal:  Drug News Perspect       Date:  2010-05

3.  Influence of MIF, CD40, and CD226 polymorphisms on risk of rheumatoid arthritis.

Authors:  Ruiping Liu; Nanwei Xu; Xinxiang Wang; Li Shen; Gongyin Zhao; Hui Zhang; Weimin Fan
Journal:  Mol Biol Rep       Date:  2012-06       Impact factor: 2.316

4.  Macrophage migration inhibitory factor enzymatic activity, lung inflammation, and cystic fibrosis.

Authors:  Huzaifa Adamali; Michelle E Armstrong; Anne Marie McLaughlin; Gordon Cooke; Edward McKone; Christine M Costello; Charles G Gallagher; Lin Leng; John A Baugh; Günter Fingerle-Rowson; Richard J Bucala; Paul McLoughlin; Seamas C Donnelly
Journal:  Am J Respir Crit Care Med       Date:  2012-05-16       Impact factor: 21.405

5.  Macrophage migration inhibitory factor and its genetic association with arthritis: a work in progress.

Authors:  Timothy R D J Radstake; Richard Bucala
Journal:  Curr Rheumatol Rep       Date:  2007-10       Impact factor: 4.592

Review 6.  Macrophage migration inhibitory factor manipulation and evaluation in tumoral hypoxic adaptation.

Authors:  Millicent Winner; Lin Leng; Wayne Zundel; Robert A Mitchell
Journal:  Methods Enzymol       Date:  2007       Impact factor: 1.600

Review 7.  MIF family cytokines in cardiovascular diseases and prospects for precision-based therapeutics.

Authors:  Pathricia V Tilstam; Dake Qi; Lin Leng; Lawrence Young; Richard Bucala
Journal:  Expert Opin Ther Targets       Date:  2017-07       Impact factor: 6.902

8.  Modeling Informatively Missing Genotypes in Haplotype Analysis.

Authors:  Nianjun Liu; Richard Bucala; Hongyu Zhao
Journal:  Commun Stat Theory Methods       Date:  2009       Impact factor: 0.893

9.  Influence of the MIF polymorphism -173G > C on Turkish postmenopausal women with osteoporosis.

Authors:  A Z Ozsoy; N Karakus; S Tural; S Yigit; N Kara; G Alayli; M K Tumer; O Kuru
Journal:  Z Rheumatol       Date:  2018-09       Impact factor: 1.372

10.  Genotyping of macrophage migration inhibitory factor (MIF) CATT₅₋₈ repeat polymorphism by denaturing high-performance liquid chromatography (DHPLC).

Authors:  Michele Benigni; Stefania Battistini; Claudia Ricci
Journal:  Mol Biotechnol       Date:  2013-07       Impact factor: 2.695

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.